During the past decade, Institut National de Recherche Biomédicale conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Institut National de Recherche Biomédicale" #1 collaborator was "Institut National de Recherche Biomédicale. Kinshasa, République Démocratique du Congo" with 3 trials as a collaborator, "Institute of Tropical Medicine, Belgium" with 2 trials as a collaborator, "Sihanouk Hospital Center of HOPE" with 2 trials as a collaborator, "B.P. Koirala Institute of Health Sciences" with 1 trials as a collaborator and "Cheikh Anta Diop University, Senegal" with 1 trials as a collaborator. Other collaborators include 6 different institutions and companies that were collaborators in the rest 16 trials.

According to Clinical.Site data, the most researched conditions in "Institut National de Recherche Biomédicale" are "Amoebic Liver Abscess" (1 trials), "Blood Stream Infections" (1 trials), "Brucellosis" (1 trials), "Enteric Fever" (1 trials) and "Fever" (1 trials). Many other conditions were trialed in "Institut National de Recherche Biomédicale" in a lesser frequency.

Most popular intervention types in "Institut National de Recherche Biomédicale" are "Device" (1 trials), "Diagnostic Test" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Blood sampling" (1 trials), "Card Agglutination Trypanosoma Test (CATT)-10" (1 trials), "Deeplex test, MolBio TrueNat for 2nd line, GeneXpert 2nd line" (1 trials), "Fluorescein DiAcetate (FDA) Microscopy,GeneXpert Ct value, pre-rRNA synthesis" (1 trials) and "HAT Serostrip" (1 trials). Other intervention names were less common.

The vast majority of trials in "Institut National de Recherche Biomédicale" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Institut National de Recherche Biomédicale". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Institut National de Recherche Biomédicale, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Institut National de Recherche Biomédicale, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".